Home / All Categories / Pharma & Healthcare / Global Irritable Bowel Syndrome (IBS) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Irritable Bowel Syndrome (IBS) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Irritable Bowel Syndrome (IBS) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Pages: 102      Published Date: Oct 2019       Category: Pharma & Healthcare
Description

Scope of the Report:
The global Irritable Bowel Syndrome (IBS) market is valued at 3147.9 million USD in 2018 and is expected to reach 5565.6 million USD by the end of 2024, growing at a CAGR of 15.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Irritable Bowel Syndrome (IBS).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Irritable Bowel Syndrome (IBS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Irritable Bowel Syndrome (IBS) market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Allergan
    IM HealthScience
    Sucampo Pharmaceuticals
    Bausch Health
    Astellas Pharmaceuticals
    Takeda
    Sebela Pharmaceuticals
    McNeil Consumer Healthcare

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    IBS-D Drug
    IBS-C Drug
    Other

Market Segment by Applications, can be divided into
    Women
    Men
Table of Contents

1 Irritable Bowel Syndrome (IBS) Market Overview
    1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS)
    1.2 Classification of Irritable Bowel Syndrome (IBS) by Types
        1.2.1 Global Irritable Bowel Syndrome (IBS) Revenue Comparison by Types (2019-2024)
        1.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Types in 2018
        1.2.3 IBS-D Drug
        1.2.4 IBS-C Drug
        1.2.5 Other
    1.3 Global Irritable Bowel Syndrome (IBS) Market by Application
        1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Women
        1.3.3 Men
    1.4 Global Irritable Bowel Syndrome (IBS) Market by Regions
        1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) Irritable Bowel Syndrome (IBS) Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Irritable Bowel Syndrome (IBS) Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Irritable Bowel Syndrome (IBS) Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) Irritable Bowel Syndrome (IBS) Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Irritable Bowel Syndrome (IBS) Status and Prospect (2014-2024)
    1.5 Global Market Size of Irritable Bowel Syndrome (IBS) (2014-2024)
2 Company Profiles
    2.1 Allergan
        2.1.1 Business Overview
        2.1.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.2 IM HealthScience
        2.2.1 Business Overview
        2.2.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Sucampo Pharmaceuticals
        2.3.1 Business Overview
        2.3.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Bausch Health
        2.4.1 Business Overview
        2.4.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Astellas Pharmaceuticals
        2.5.1 Business Overview
        2.5.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Takeda
        2.6.1 Business Overview
        2.6.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Sebela Pharmaceuticals
        2.7.1 Business Overview
        2.7.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
    2.8 McNeil Consumer Healthcare
        2.8.1 Business Overview
        2.8.2 Irritable Bowel Syndrome (IBS) Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Irritable Bowel Syndrome (IBS) Market Competition, by Players
    3.1 Global Irritable Bowel Syndrome (IBS) Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Irritable Bowel Syndrome (IBS) Players Market Share
        3.2.2 Top 10 Irritable Bowel Syndrome (IBS) Players Market Share
    3.3 Market Competition Trend
4 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
    4.1 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions
    4.2 North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    4.3 Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    4.5 South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
5 North America Irritable Bowel Syndrome (IBS) Revenue by Countries
    5.1 North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
    5.2 USA Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    5.3 Canada Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    5.4 Mexico Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
6 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries
    6.1 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
    6.2 Germany Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    6.3 UK Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    6.4 France Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    6.5 Russia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    6.6 Italy Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries
    7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
    7.2 China Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    7.3 Japan Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    7.4 Korea Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    7.5 India Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
8 South America Irritable Bowel Syndrome (IBS) Revenue by Countries
    8.1 South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
    8.2 Brazil Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    8.3 Argentina Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    8.4 Colombia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Irritable Bowel Syndrome (IBS) by Countries
    9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
    9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    9.3 UAE Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    9.4 Egypt Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    9.5 Nigeria Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
    9.6 South Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
10 Global Irritable Bowel Syndrome (IBS) Market Segment by Type
    10.1 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
    10.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2019-2024)
    10.3 IBS-D Drug Revenue Growth Rate (2014-2024)
    10.4 IBS-C Drug Revenue Growth Rate (2014-2024)
    10.5 Other Revenue Growth Rate (2014-2024)
11 Global Irritable Bowel Syndrome (IBS) Market Segment by Application
    11.1 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2014-2019)
    11.2 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2019-2024)
    11.3 Women Revenue Growth (2014-2019)
    11.4 Men Revenue Growth (2014-2019)
12 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2019-2024)
    12.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2019-2024)
    12.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2019-2024)
    12.3 North America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
    12.4 Europe Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
    12.6 South America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure Irritable Bowel Syndrome (IBS) Picture
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Table Global Irritable Bowel Syndrome (IBS) and Revenue (Million USD) Market Split by Product Type
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Types in 2018
Figure IBS-D Drug Picture
Figure IBS-C Drug Picture
Figure Other Picture
Table Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Application (2014-2024)
Figure Irritable Bowel Syndrome (IBS) Revenue Market Share by Applications in 2018
Figure Women Picture
Figure Men Picture
Table Global Market Irritable Bowel Syndrome (IBS) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Type and Applications
Table Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table IM HealthScience Basic Information, Manufacturing Base and Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Type and Applications
Table IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Irritable Bowel Syndrome (IBS) Type and Applications
Table Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Type and Applications
Table Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Type and Applications
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Players (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Players (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Players in 2017
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Players in 2018
Figure Global Top 5 Players Irritable Bowel Syndrome (IBS) Revenue Market Share in 2018
Figure Global Top 10 Players Irritable Bowel Syndrome (IBS) Revenue Market Share in 2018
Figure Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Regions (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2018
Figure North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure USA Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Canada Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Mexico Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Germany Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure UK Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure France Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Russia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Italy Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure China Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Japan Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Korea Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure India Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Table South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Brazil Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Argentina Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Colombia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure UAE Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Egypt Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure Nigeria Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Figure South Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Type (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Type in 2018
Table Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2019-2024)
Figure Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2019-2024)
Figure Global IBS-D Drug Revenue Growth Rate (2014-2019)
Figure Global IBS-C Drug Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Application (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Share by Application in 2018
Table Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Application (2019-2024)
Figure Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2019-2024)
Figure Global Women Revenue Growth Rate (2014-2019)
Figure Global Men Revenue Growth Rate (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2019-2024)
Allergan
    IM HealthScience
    Sucampo Pharmaceuticals
    Bausch Health
    Astellas Pharmaceuticals
    Takeda
    Sebela Pharmaceuticals
    McNeil Consumer Healthcare
Request sample
If you need any reports sample, just let us know
Request message: *
Your Name: *
Email Address: *
Country:
Phone Number:
Verification code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License $3,480.00
Multi User License $5,220.00
Corporate Users License $6,960.00
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico